000790 Share Price Performance
CN¥3.80
-0.41 (-9.74%)
Price CN¥3.80
Share PriceCN¥3.80
What Chengdu huasun technology group Inc. , LTD.'s (SZSE:000790) 30% Share Price Gain Is Not Telling You
Oct 28
Chengdu huasun technology group Inc. , LTD. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
000790 Community Narratives
There are no narratives available yet.
Recent 000790 News & Updates
Chengdu huasun technology group Inc. , LTD. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 30, 2025
- Earnings per share (EPS)
- -0.11
- Gross Margin
- 51.30%
- Net Profit Margin
- -10.12%
- Debt/Equity Ratio
- 33.7%
Chengdu huasun technology group Inc. , LTD. Competitors
Snowflake Analysis
About 000790
- Founded
- 1988
- Employees
- 918
- CEO
- WebsiteView website
Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs; and medicines for the treatment of cardiovascular and cerebrovascular diseases. In addition, the company designs, produces, installs, and services steel structure buildings. The company was formerly known as Chengdu Taihe Health Technology Group Inc., Ltd. and changed its name to Chengdu huasun technology group Inc. , LTD. in April 2020. The company was founded in 1988 and is based in Chengdu, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 1.8%
- 3 Months: 18.3%
- 1 Year: 24.1%
- Year to Date: 26.2%
The Industrials sector has led the market, which has gained 1.8%. As for the past 12 months, the market is up 24%. Looking forward, earnings are forecast to grow by 27% annually. Market details ›